What is the Impact Factor of Clinical Breast Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Clinical Breast Cancer is 2.70, ranking in quartile Q3 of Web of Science (SCIE).

Is Clinical Breast Cancer indexed in Web of Science or Scopus?

Yes, Clinical Breast Cancer is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.932 (Q2) and an H-index of 88.

Who publishes Clinical Breast Cancer and what is the Article Processing Charge (APC)?

Clinical Breast Cancer is published by Elsevier. The estimated Article Processing Charge (APC) is approximately $3,276 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Clinical Breast Cancer?

The official ISO-4 abbreviation of Clinical Breast Cancer is "CLIN BREAST CANCER" with common acronym "cbc". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #5,491Hybrid

Clinical Breast Cancer

Acronym:cbc

•

Abbreviation (ISO):CLIN BREAST CANCER

•

Identifier (ISSN):1526-8209(Print)/1938-0666(Online)

•

Publisher:Elsevier

Official Website Submission Portal Compare

Clarivate IF (2026)

2.7↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical Breast Cancer

WoS Q3

Annual Impact Factor Metric

Current (2026):2.7

Scopus SJR & RankScopus Q2

0.932

#5,491

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

88 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate3.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

146articles/year

14.34% Gold OA•85.53% Original Research

Aims & Scope

Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.

Topics Covered (Recognized by AI)

MedicineInternal MedicineBiologyGeneticsOncology & Cancer ResearchOncologyPathologySurgeryMathematicsChemistryRadiologyStatistics

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank185/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank202/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	185/333	Q3
ONCOLOGY	JCISCIE	202/333	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.7

Articles / Year171

Total Citations34

2025

IF2.5

Articles / Year245

Total Citations415

2024

IF2.9

Articles / Year234

Total Citations1,047

2023

IF3.1

Articles / Year171

Total Citations1,285

2022

IF3.078

Articles / Year161

Total Citations1,455

Year	Impact Factor	Articles / Year	Total Citations
2026	2.7	171	34
2025	2.5	245	415
2024	2.9	234	1,047
2023	3.1	171	1,285
2022	3.078	161	1,455
2021	3.225	187	2,834
2020	2.647	191	4,008
2019	2.762	163	3,023
2018	2.703	192	4,758
2017	—	203	5,664
2016	—	124	3,225
2015	—	107	2,449

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,491Scopus Q2SCImago Profile

Scopus Coverage:2000-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.932

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.72

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,276 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,507

3-Year Documents535

Citable Documents510

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate51.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ2

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Breast Cancer (acronym: cbc, abbr: CLIN BREAST CANCER, ISSN: 1526-8209) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in United States since 2000. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.932 (Q2), an H-index of 88.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 146 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,276 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.